Cyclosporin A inhibits activation of inducible nitric oxide synthase in C6 glioma cell line

Brain Research

Volumn 816, Issue 1, 1999, Pages 92-98

  Trajković, Vladimir ^a   Badovinac, Vladimir ^a   Janković, Vladimir ^a   Stojković, Mostarica Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

C6; Cyclosporin A; FK506; Glioma; iNOS; Nitric oxide; Rat

Indexed keywords

CALCINEURIN; CYCLOHEXIMIDE; CYCLOSPORIN A; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TACROLIMUS;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033573754     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01130-5     Document Type: Article

References (44)

1. Albina J.E., Abate J.A., Henry W.L. Jr. Nitric oxide production is required for murine resident macrophages to suppress mitogen-stimulated T-cell proliferation. J. Immunol. 147:1991;144-148.
2. Baldwin A.S. Jr. The NF-κB and I-κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
3. Benbernou N., Esnault S., Shin H.C.K., Fekkar H., Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T-cells by cyclic AMP-dependent signal transduction. Immunology. 91:1997;361-368.
4. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
5. Bogdan C., Thuring H., Dlaska M., Rollinghoff M., Weiss G. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of macrophage population. J. Immunol. 159:1997;4506-4513.
6. Bolton C., Borel J.F., Cuzner M.L., Davison A.N., Turner A.M. Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J. Neurol. Sci. 56:1982;147-153.
7. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
8. Chung I.Y., Norris J.G., Benveniste E.N. Differential tumor necrosis factor-alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173:1991;801-811.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Conde M., Andrade J., Bedoya F.J., Maria C.S., Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: evidence of a direct effect on nitric oxide synthase activity. Immunology. 84:1995;476-481.
11. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
12. Ding M., Zhang M., Wong J.L., Rogers N.E., Ignarro L.J., Voskuhl R.R. Antisense knock-down of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:1998;2560-2564.
13. Faulds D., Goa K.L., Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 45:1993;953-1040.
14. Feinstein D.L., Galea E., Roberts S., Berquist H., Wang H., Reis D.J. Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62:1994;315-321.
15. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking NOS2 gene. J. Immunol. 160:1998;2940-2946.
16. Frantz B., Nordby E.C., Bren G., Steffan N., Paya C.V., Kincaid R.L., Tocci M.J., O'Keefe S.J., O'Neill E.A. Calcineurin acts in synergy with PMA to inactivate I-κB/MAD3, an inhibitor of NF-κB. EMBO J. 13:1994;861-870.
17. Furman I., Baudet C., Brachet P. Differential expression of M-CSF, LIF, and TNF-α genes in normal and malignant rat glial cells: regulation by lipopolysaccharide and vitamin D. J. Neurosci. Res. 46:1996;360-366.
18. Galea E., Feinstein D.L., Reis D.J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA. 89:1992;10945-10949.
19. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of the experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
20. Hattori Y., Nakanishi N. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell. Immunol. 165:1995;7-11.
21. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:1993;229-232.
22. Hibbs J.B., Taintor R., Vavrin Z., Rachlin E. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys Res. Commun. 157:1989;87-94.
23. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Im K.S., Kimura T., Green S., Mak T.W., Taniguchi T., Vilcek J. Requirements for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
24. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally-induced neurologic diseases. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
25. Kunz D., Walker G., Eberhardt W., Nitsch D., Pfeilschifter J. Interleukin-1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem. Biophys. Res. Commun. 216:1995;438-446.
26. Liew F.Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:1995;396-399.
27. Lukić M.L., Stosšić-Grujiáčić S., Ostojić N., Chan W.L., Liew F.Y. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178:1991;913-918.
28. MacMicking J., Xie Q.-W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
29. Martin E., Nathan C., Xie Q.-W. Role of interferon regulatory factor-1 (IRF-1) in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
30. Marumo T., Nakaki T., Hishikawa K., Suzuki H., Kato R., Saruta T. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension. 25:1995;764-768.
31. Mosieniak G., Figiel I., Kaminska B. Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. J. Neurochem. 68:1997;1142-1149.
32. Muhl H., Kunz D., Rob P., Pfeilschifter J. Cyclosporin derivatives inhibit interleukin-1β induction of nitric oxide synthase in renal mesangial cells. Eur. J. Pharmacol. 249:1993;95-100.
33. Mustafa M., Diener P., Sun J.B., Link H., Olsson T. Immunopharmacologic modulation of experimental allergic encephalomyelitis: low-dose cyclosporin A treatment causes disease relapse and increased systemic T- and B-cell-mediated myelin-directed autoimmunity. Scand. J. Immunol. 38:1993;499-507.
34. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
35. Polman C.H., Matthaei I., de Groot C.J., Koetsier J.C., Sminia T., Dijkstra C.D. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 17:1988;209-216.
36. Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
37. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK 506. Immunol. Today. 13:1992;136-142.
38. Shatrov V.A., Lehmann V., Chouaib S. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-κB in U937 cells. Biochem. Biophys. Res. Commun. 234:1997;121-124.
39. Shin W.S., Hong Y.H., Peng H.B., Decaterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ: the role of constitutive NF-κB activity. J. Biol. Chem. 271:1996;11317-11324.
40. Simons M.L., Murphy S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:1992;897-905.
41. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T-helper type-1 and T-helper type-2 cells. Eur. J. Immunol. 24:1994;980-984.
42. Tran E.H., Hardinpouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
43. Xie Q.-W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in the induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
44. Zhang J., Steiner J.R. Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. Neurol. Res. 269:1995;285-288.